Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Mol Cell Endocrinol ; 499: 110586, 2020 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-31539598

RESUMEN

Placental syncytiotrophoblast (ST) is considered as the main placental endocrine tissue secreting progesterone, a steroid essential for maintenance of pregnancy. However, each step of progestins production has been poorly investigated in villous cytotrophoblast (VCT) regarding ST formation. We aimed to characterize progestins production during human differentiation of VCT into ST. VCTs were isolated from term placenta and cultivated, with or without forskolin (FSK), to stimulate trophoblast differentiation. Secreted progestins concentrations were determined by immuno-assay and Gas Chromatography-tandem mass spectrometry. Intracellular expression of cholesterol transporter and enzymes involved in steroidogenesis were studied by immunofluorescence, western-blot, and RT-qPCR. Progesterone and pregnenolone are produced by VCT and their secretion increases with VCT differentiation while 17-hydroxyprogesterone concentration remains undetectable. HSD3B1 enzyme expression increases whereas MLN64, the cholesterol placental mitochondrial transporter and P450SCC expressions do not. FSK induces progestins production. Progestins placental synthesis is effective since VCT and increases with ST formation thanks to mitochondria.


Asunto(s)
Complejos Multienzimáticos/metabolismo , Placenta/metabolismo , Progesterona Reductasa/metabolismo , Progestinas/metabolismo , Esteroide Isomerasas/metabolismo , Factor 4 Asociado a Receptor de TNF/metabolismo , Trofoblastos/citología , 17-alfa-Hidroxiprogesterona/metabolismo , Diferenciación Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Colforsina/farmacología , Femenino , Cromatografía de Gases y Espectrometría de Masas , Regulación de la Expresión Génica , Humanos , Complejos Multienzimáticos/genética , Embarazo , Pregnenolona/metabolismo , Progesterona/metabolismo , Progesterona Reductasa/genética , Esteroide Isomerasas/genética , Factor 4 Asociado a Receptor de TNF/genética , Trofoblastos/metabolismo
2.
Mol Cell Endocrinol ; 450: 105-112, 2017 07 15.
Artículo en Inglés | MEDLINE | ID: mdl-28461075

RESUMEN

Ovarian monitoring requires the determination of serum estradiol and progesterone levels. We investigated whole follicular steroidogenesis under rFSH in medically assisted procreation (MAP: 26 IVF, 24 ICSI) compared to 11 controls (IUI). Estrone, estradiol, Δ4-androstenedione, testosterone, progesterone and 17-hydroxyprogesterone were measured by immunoassay and mass spectrometry except for estrogens. At the start of a spontaneous or induced cycle, steroids levels fluctuated within normal ranges: estradiol (314-585 pmol/L), estrone (165-379 pmol/L) testosterone (1.3-1.6 nmol/L), Δ4-androstenedione (4.5-5.6 nmol/L), 17-hydroxyprogesterone (2.1-2.2 nmol/L) and progesterone (1.8-1.9 nmol/L). 17-hydroxyprogesterone, Δ 4-androstenedione and estradiol predominated. Then estradiol and oestrone levels rise, but less markedly for oestrone in IUI. In MAP, rFSH injections induce a sharp increase in estrogens associated with a rise in 17-hydroxyprogesterone and Δ4-androstenedione levels, disrupting oestrogen/androgen ratios. rFSH stimulation induces an ovarian hyperplasia and Δ4pathway which could become abnormal. Determining 17-hydroxyprogesterone and Δ4-androstenedione levels with LC-MS/MS may therefore be useful in managing recurrent MAP failures.


Asunto(s)
17-alfa-Hidroxiprogesterona/sangre , Androstenodiona/sangre , Hormona Folículo Estimulante/farmacología , Espectrometría de Masas , Folículo Ovárico/patología , Proteínas Recombinantes/farmacología , Reproducción/efectos de los fármacos , Femenino , Humanos , Hiperplasia , Folículo Ovárico/efectos de los fármacos , Estudios Retrospectivos
3.
Free Radic Biol Med ; 51(8): 1583-8, 2011 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-21827848

RESUMEN

Impaired glucose tolerance is common during aging. The transcription factor PAX6 is involved in glucose homeostasis. Computational promoter sequence analysis of the catalase gene highlighted a putative PAX6 binding site on the rs769214 polymorphism A allele. Creation of this binding site has been suggested to explain renutrition inefficiency in malnourished elderly patients. Our aim was to evaluate the link between the rs769214 polymorphism of the catalase gene and glucose homeostasis in malnourished elderly patients at inclusion and during renutrition. Thirty-three malnourished elderly Caucasian inpatients were recruited. Nutritional and inflammatory statuses were assessed and a multiplex adipokine analysis was conducted at inclusion and discharge from the Geriatric Nutritional Care Unit at Charles-Foix Hospital (Ivry-sur-Seine, France). Serum glucagon, PAI-1, and TNF-α levels were significantly lower in the A-allele carriers at inclusion. During renutrition, A-allele carriers exhibited increased serum glucagon, PAI-1, and TNF-α variation. After renutrition, levels of these parameters were similar for A-allele carriers and G-allele carriers. A logistic ordinal multivariate regression analysis linked only variation of glucagon to rs769214 SNP. These results support a role for catalase SNP in the efficiency of renutrition in malnourished elderly patients via the modulation of glucagon secretion, probably involving PAX6.


Asunto(s)
Catalasa/metabolismo , Glucagón/biosíntesis , Desnutrición/genética , Anciano , Alelos , Sitios de Unión/genética , Biomarcadores Farmacológicos/sangre , Catalasa/genética , Biología Computacional , Análisis Mutacional de ADN , Proteínas del Ojo/metabolismo , Predisposición Genética a la Enfermedad , Glucagón/sangre , Glucagón/genética , Intolerancia a la Glucosa , Proteínas de Homeodominio/metabolismo , Humanos , Desnutrición/sangre , Desnutrición/dietoterapia , Factor de Transcripción PAX6 , Factores de Transcripción Paired Box/metabolismo , Inhibidor 1 de Activador Plasminogénico/sangre , Polimorfismo de Nucleótido Simple , Proteínas Represoras/metabolismo , Activación Transcripcional , Factor de Necrosis Tumoral alfa/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA